Portfolio analysis provides structured insight into how research investments are distributed, how priorities evolve over time, and where strategic opportunities may exist.

Customized analyses may include:

• Assessing NIH portfolios for specific diseases or research area

• Distinguishing substantive funding changes from reporting or coding artifacts

• Identifying gaps and emerging opportunities within research portfolios

• Mapping related research activity across federal agencies

• Developing data-driven briefing materials to support engaging policymakers

Each analysis is tailored to your organization’s specific questions and strategic objectives, with an emphasis on clarity, context, and practical application.